{
    "title": "109_hr3423",
    "content": "The Act titled \"Medical Device User Fee Stabilization Act of 2005\" is cited as the short title. Amendments to the Federal Food, Drug, and Cosmetic Act are made. Amendments are made to the Federal Food, Drug, and Cosmetic Act regarding device user fees. Changes include adjusting annual fees and setting new fee amounts for fiscal years. The amendments to the Federal Food, Drug, and Cosmetic Act include adjusting annual fees and setting new fee amounts for fiscal years 2006 and 2007. The Secretary may use unobligated carryover balances from previous fiscal years to ensure sufficient fee revenues are available, with notice required to relevant committees before fund usage. The amendments to the Federal Food, Drug, and Cosmetic Act involve redefining 'small business' as an entity with $30,000,000 or less in gross receipts. Adjustments include increasing the threshold to $100,000,000 in various paragraphs and subsections. The Secretary is expected to meet performance goals for fiscal year 2005 with appropriated funds. The text discusses the appropriation of funds for fiscal year 2005, with specific criteria for determining the amount allocated. It includes adjustments based on the percentage difference from the initial amount specified in the clause. The text discusses adjustments to the appropriation of funds for fiscal year 2005, including changes to the specified percentage difference. The text discusses amendments to the appropriation of funds for fiscal years 2006 and 2007, including changes to specific clauses and reporting requirements. The text discusses amendments to the appropriation of funds for fiscal years 2006 and 2007, including changes to specific clauses and reporting requirements related to applications, notifications, fees paid by businesses, and certification of amounts appropriated for salaries and expenses of the Food and Drug Administration. Amendments are also made to the section regarding misbranded devices, specifically reprocessed single-use devices. The text discusses requirements for reprocessed medical devices to prominently display the manufacturer's name or symbol. Guidance will be issued to clarify when this requirement is not met. The Medical Device User Fee Modernization Act of 2002 is amended to specify the effective date for devices described under the Federal Food, Drug, and Cosmetic Act. The requirement for devices to display the manufacturer's name or symbol will apply 12 months after the enactment of the Medical Device User Fee Stabilization Act of 2005. The requirement for devices to display the manufacturer's name or symbol will apply only to devices reprocessed and introduced in interstate commerce after the effective date specified in the Medical Device User Fee Modernization Act of 2002. The curr_chunk is about the roles of the Speaker of the House of Representatives and the Vice President of the United States as President of the Senate."
}